GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-01-01
著者
-
Yoshida H
National Hospital Organization Nagasaki Medical Center
-
Sakata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
久留米大学 大学院医学研究科消化器疾患情報講座
-
Sata Michio
京都府立医科大学 消化器内科学
-
Sata Michio
大腸肛門病センターくるめ病院
-
Sata Michio
久留米大学 医学部消化器外科
-
Okita K
Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine
-
Okita Kiwamu
山口大学 医学部消化器病態内科
-
Okita Kiwamu
下関厚生病院(社保)
-
Okita Kiwamu
京都府立医科大学 消化器内科学
-
Iwahashi Hiromi
Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine
-
OSHITA Masahide
Osaka Police Hospital
-
YOSHIHARA Harumasa
Osaka Rousai Hospital
-
Haruna Yoshimichi
大阪大学 医学系研究科消化器内科学
-
Oshita Masahide
Department Of Internal Medicine Osaka Police Hospital
-
Oshita Masahide
大阪大学 医学系研究科消化器内科
-
Ohkawa Kazuyoshi
大阪大学
-
Ogata Kei
久留米大学 医学部第2内科消化器内科部門
-
Ogata Kei
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Sata Michio
久留米大学 医学部免疫学講座
-
Sata Michio
久留米大学 消化器内科
-
Sakaida Isao
First Department Of Internal Medicine School Of Medicine Yamaguchi University
-
Onji Morikazu
Department Of Gastroenterology And Metabology Ehime University Graduate School Of Medicine
-
Onji Morikazu
Department Of Gastroenteology And Metabology Ehime University Graduate School Of Medicine
-
Tajiri Takashi
Department Of Surgery Nippon Medical School
-
OHO Kazuhiko
Clinical Research Committee of the Japan Society for Portal Hypertension
-
KOKUBU Shigehiro
Clinical Research Committee of the Japan Society for Portal Hypertension
-
HASUMI Akitake
Clinical Research Committee of the Japan Society for Portal Hypertension
-
MURASHIMA Naoya
Clinical Research Committee of the Japan Society for Portal Hypertension
-
Yotsuyanagi Hiroshi
Department Of Gastroenterology-hepatology St. Marianna Medical College
-
Murashima S
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Okita Kiwamu
Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine
-
Okita K
Yamaguchi Univ. Yamaguchi Jpn
-
Okita K
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Omori Kaoru
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Yoshida H
Department Of Internal Medicine Division Of Gastroenterology And Hepatology St. Marianna University
-
Yotsuyanagi Hiroshi
National Hospital Organization Nagasaki Medical Center
-
Okita Kiwamu
First Department Of Internal Medical Yamaguchi University School Of Medicine
-
Yoshida Tomoharu
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Sata Michio
2nd Department Of Medicine Kurume University School Of Medicine
-
Okita Mika
Department Of Molecular Gastroenterology & Hepatology Kyoto Prefectural University Graduate Scho
-
Onji Morikazu
Department Of Gastroenrerology And Metabology Ehime University Graduate School Of Medicine
-
Sata Michio
Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine
-
Sata Michio
Departments Of Internal Medicine Kurume University School Of Medicine
-
Ohta Mitsuhiro
Department Of Pediatrics Saga Medical School
-
Futagawa Shunji
Department Of Hepatobiliary Pancreatic Surgery Iuntendo University School Of Medicine
-
Okita K
First Department Of Internal Medicine Yamaguchi University School Of Medicine
-
Kokudo Norihiro
Dept Surgery Univ Tokyo
-
Kokudo Norihiko
Hepato-biliary-pancreatic Surgery Division Department Of Surgery Graduate School Of Medicine Univers
-
Okita Kiwamu
Social Insurance Alliance Shimonoseki Kohsei Hospital
-
Yoshihara Harumasa
Department Of Internal Medicine Osaka Rosai Hospital
-
Okita Kiwamu
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Yoshida Tomoharu
The Japan Society For Portal Hypertension
-
TAJIRI TAKASHI
The Japan Society for Portal Hypertension
-
YOSHIDA HIROSHI
The Japan Society for Portal Hypertension
-
OBARA KATSUTOSHI
The Japan Society for Portal Hypertension
-
ONJI MORIKAZU
The Japan Society for Portal Hypertension
-
KAGE MASAYOSHI
The Japan Society for Portal Hypertension
-
KITANO SEIGO
The Japan Society for Portal Hypertension
-
KOKUDO NORIHIRO
The Japan Society for Portal Hypertension
-
KOKUBU SHIGEHIRO
The Japan Society for Portal Hypertension
-
SAKAIDA ISAO
The Japan Society for Portal Hypertension
-
SATA MICHIO
The Japan Society for Portal Hypertension
-
TAJIRI HISAO
The Japan Society for Portal Hypertension
-
TSUKADA KAZUHIRO
The Japan Society for Portal Hypertension
-
NONAMI TOSHIAKI
The Japan Society for Portal Hypertension
-
HASHIZUME MAKOTO
The Japan Society for Portal Hypertension
-
HIROTA SHOUZOU
The Japan Society for Portal Hypertension
-
MURASHIMA NAOYA
The Japan Society for Portal Hypertension
-
MORIYASU FUMINORI
The Japan Society for Portal Hypertension
-
SAIGENJI KATSUNORI
The Japan Society for Portal Hypertension
-
MAKUUCHI HIROYASU
The Japan Society for Portal Hypertension
-
OHO KAZUHIKO
The Japan Society for Portal Hypertension
-
SUZUKI HIROAKI
The Japan Society for Portal Hypertension
-
HASUMI AKITAKE
The Japan Society for Portal Hypertension
-
OKITA KIWAMU
The Japan Society for Portal Hypertension
-
FUTAGAWA SHUNJI
The Japan Society for Portal Hypertension
-
IDEZUKI YASUO
The Japan Society for Portal Hypertension
-
Kumada Takashi
The Japan Society For Portal Hypertension
-
Yoshihara Harumasa
Department Of Gastroenterology And Metabology Ehime University Graduate School Of Medicine
-
Sakamoto Minoru
First Department Of Internal Medicine University Of Yamanashi
-
Onji Morikazu
Department Of Medical Biochemistry Kobe Pharmaceutical University
-
TAJIRI Takashi
Department of Surgery, Nippon Medical School
関連論文
- Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease
- Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
- Human primary cultured hepatic stellate cells can be cryopreserved
- High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
- Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
- Periostin and bone marrow fibrosis
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Keratin inclusions alter cytosolic protein localization in hepatocytes
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
- Angiogenic cell therapy for hepatic fibrosis
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
- Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
- Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
- Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
- Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
- Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection
- Impaired Gastric Motility in Patients with Functional Dyspepsia
- Improvement of gastric motility by hemodialysis in patients with chronic renal failure
- Effects of endothelin-1 on the membrane potential and slow waves in circular smooth muscle of rat gastric antrum
- Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
- Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
- Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
- Systemic Sclerosis Associated with Diabetes Insipidus
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
- Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
- ANTI-TGF-β INTERVENTION INHIBITS PROGRESSION OF HEPATIC FIBROSIS
- RHO SIGNALING IS REQUIRED FOR MECHANICAL STRETCH-INDUCED TGF-β PRODUCTION IN HEPATIC STELLATE CELLS
- CHANGES OF CELL, EXTRACELLULAR MATRIX, APOPTOSIS AND ANGlOGENESIS IN HEPATIC INJURY AND REPAIR
- Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- Involvement of GBV-C/HGV in liver diseases in Japan
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
- Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
- Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
- Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
- Serological Study of Bartonella henselae in Cat Scratch Disease in Japan
- Relapsing Polychondritis Associated with Subclinical Sjogre's Syndrome and Phlegmon of the Neck
- Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
- Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
- Liver-Associated Natural Killer Activity in Cirrhotic Rats
- Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
- GASTRIC SCHWANNOMA WITH ADJACENT EXTERNAL PROGRESSION HARBORED ABERRANT NF2 GENE
- Protonation-Induced Conformational Changes of N,N,N',N'-Tetramethylethylenediamine. Importance of Strong N-H^+…N Hydrogen Bonding
- Conformational Order of the Alkyl Chain in a Nonionic Surfactant α-Dodecyl-ω-hydroxytris (oxyethylene) (C_E_3) in Water
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
- Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- AN ENDOCRINE CELL CARCINOMA WITH GASTRIC-AND-INTESTINAL MIXED PHENOTYPE ADENOCARCINOMA COMPONENT IN THE STOMACH
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
- Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy